The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Q4 and full year financials on 3rd March:
https://www.veronapharma.com/media/verona-pharma-report-fourth-quarter-and-full-year-2021-financial
Latest update for those genuinely invested, Enhance 2 completed recruitment and in course to report in Q3 this year:
https://www.veronapharma.com/media/verona-pharma-completes-enrollment-phase-3-enhance-2-trial
Not too much off a break for me this Christmas as very busy. However yes a meet up in summertime would be great. Yes I am hoping Tern does well Izstar. Maybe more eggs than I should probably have in that particular basket. LOL. Managed to buy Vrna at the bottom. Sold 60% in the $6.50 region to get a near 40% free carry. Will do that again if the opportunity arises. Keep well and good health and happiness to you both and you and yours and those wishes are extended to Bewise and all other LTH holders.
And digger well done for keeping the faith - sold out at a huge loss when they ceased trading on uk exchange - final straw but so see rhodi we have something in common - TERN - hopefully better luck this time
sorry, missed these posts and so can only hope that break was good to you. It would be absolutely great to meet up for that long promised pint - maybe June/July when weather is better
ATB
Hi Rhodi, good to see that you are still in touch with Vrna with a bit of a stake!
I still have my original stake, albeit heavily diluted, but still enough to keep a keen eye on progress.
The recent cardiac results were good and no doubt required by the FDA. I also remember there were cases in an earlier trial, with an
Increase in heart rate, so it’s good that is not deemed to be problem. I am also very happy that the P3 end point targets are based on FEV and general improvement in well being. FEV has always been good in every previous trial, so I personally believe that the prospects for success are good, and on that basis, I look forward to 2022.
I wish you and Izstar all the best for Xmas and hope we can meet under better circumstances next year.
Well back in at a fraction over £4 so just an interest play. Not even a 20th of what I held at the peak of in vestment in here. Almost tempted to sell and free carry. Then buy some more when it returns to £4. That way I can still keep the money working. May see what it does up to Christmas. Anyway Digger and Izstar hopefully next year we can finally arrange the get together. Enjoy Christmas with family. Keep safe and all LTH stay well and may you all have a prosperous 2021.
Hi all, I’m reaching out for some pointers to who you used to convert the share certificates to ADS. I’ve had limited time to deal with the situation but every broker I’ve tried cannot fulfil the transaction, mainly due to restricted services. Any advice would be welcome.
.
https://www.veronapharma.com/media/verona-pharma-reports-third-quarter-2021-financial-results-and
I can't help feeling that something might be afoot with VRNA. I can't remember a time when there is just no news coming out of the company for so long.. we have all been focused on the phase 111 development but when was the last time anone heard any news about the other trials like the other version of ensifentrine or asthma or cystic fibrosis. Someone came up with a lovely description before of Shaking the tree and maybe thats what the company is allowing to happen before serious news is reported, just to punish the doubters.
I can't believe any company interested in this company will wait until 2022/3 to make a move as they would pay through the nose by then.
Haha, knew you hadn't filtered me rhodi, it was obvious from your post on 29th Sept. Absolutely pathetic.
Dead money? With phase 3 results out next year, China deal signed and price target of 25 bucks...hardly dead...
Good luck buying in again, every time I try to top up there's no liquidity...think you've missed out....
Imo it will be worth waiting as more institutional sellers abandon VRNA for better prospects else where at the moment. I will maybe get back in closer to $4 with a small 5 figure sum. If it does not get to that level then no worries.Not worth getting in at anything higher as nothing happening here until later in 2022 and it remains just dead money. It would be interesting to see how much VRNA is being shorted as have not really looked lately. Anyway all lth's hope you are all well.
One of the sad effects of covid is that I need to filter more and more idiotic posters and green boxes seem to abound lol.
Brilliant rhodi. You ambition to break even after such a long time has been achieved. Huzzah.
Yes that would be great and hopefully digger will see message and will be up for it also. Hope you and your family are all well. Looking forward to the met up. Fortunately I have done well with the investment that I pulled out of Verona Pharma which would have depreciated further in Verona Pharma and be worth even less now. Have pulled back all losses incurred her but hope at some stage it comes good for Digger, Bewise and the other LTH's.
Rhodi
Yes let’s meet up in Brum with digger - maybe November?
Poor rhodi - sold too early and now can't buy back in.
Two phase 3 trials due to report next year.
Deal done in China.
HC Wainwright announces SP target of $25
Just had to be patient and hold your nerve rhodi but you blew it.
Blast from the past. Hope you are well and that life is being kind to you and that you and your family are keeping in good health. All the best for any of your current investments. Do you still hold here?
Well well well my old sparring partner is still here lol. What a huge white elephant this company turned out to be. Hope you are well and living life. All the very best to you.
Nearly a year on from joining Nasdaq and the share has yet again dropped in value. Those Institutional investors that by all accounts carried out due diligence and looked at the IP that Verona Pharma had must be so embarrassed at the ever falling SP. Surprised they have not exited at this Jam Tomorrow company that fails to deliver time after time.
So a year on the board realize that it was not AIM that was a drag on the company sp. But it was more likely investors can see it is a very much a lifestyle company as someone once called it. Successive boards have failed at each and every turn and the current sp speaks volumes and dose not lie. Very sorry for all investors who have lost and continue to lose money here. The best decision I ever made was to exit here and have since clawed back considerable losses attributed to my mistake in believing what the board stated "significant shareholder value".
Hoping that Digger and Bewise and others come good before they are pushing up daisies but before 2023 how many better opportunities have been lost to loyal investors here.
Still watch it in hope more than any expectation. Above is my opinion but still reckon this will see $5 before it sees $15. Sorry we may miss the reunion but if Izstar or Digger wish to still meet up this year I am still up for it. Saw you post once on the other board Izstar and I hope you invested as much as I did at the 8p levels.
https://www.veronapharma.com/media/verona-pharma-reports-second-quarter-2021-financial-results-and
Bloody hell, what is going on with this share price? I am getting seriously fed up with this bunch, always jam tomorrow!
Under the terms of the agreement, Verona Pharma has granted Nuance Pharma the exclusive rights to develop and commercialize ensifentrine in Greater China. In return, Verona Pharma will receive an upfront payment of $25 million in cash and an equity interest currently valued at $15 million in Nuance Biotech, the parent company of Nuance Pharma. Verona Pharma is eligible to receive future milestone payments of up to $179 million that are triggered upon achievement of certain clinical, regulatory, and commercial milestones. Verona Pharma is also entitled to tiered double-digit royalties as a percentage of net sales in Greater China.
Nuance Pharma will be responsible for all costs related to clinical development and commercialization in Greater China. A joint steering committee will be established to ensure ensifentrine’s clinical development in the region aligns with Verona Pharma’s overall global development and commercialization strategy. Nuance Pharma intends to file a Clinical Trial Application with the China Food and Drug Administration later this year and begin clinical studies for the treatment of COPD in Greater China thereafter.
Verona have a deal with China pharma Nuance